Ocular Therapeutix (OCUL) Shares Issued (2014 - 2025)

Ocular Therapeutix's Shares Issued history runs 12 years deep, the most recent figure standing at $10.9 million for Q4 2025.

• On a quarterly basis, Shares Issued fell 45.43% year-over-year to $10.9 million in Q4 2025; TTM through Dec 2025 was $10.9 million, a 45.43% decrease from a year earlier, with the FY2025 full-year figure at $10.9 million, down 45.43% from the prior year.
• Shares Issued rose to $10.9 million in Q4 2025 per OCUL's latest filing, from $635606.0 in the prior quarter.
• Across five years, Shares Issued topped out at $19.9 million in Q4 2024 and bottomed at $398784.0 in Q4 2023.
• The 5-year median for Shares Issued is $1.5 million (2023), against an average of $4.7 million.
• Across the five-year window, Shares Issued tumbled 97.08% in 2023 and soared 4887.08% in 2024, its largest moves.
• Year by year, Shares Issued stood at $9.8 million in 2021, then soared by 39.97% to $13.7 million in 2022, then tumbled by 97.08% to $398784.0 in 2023, then surged by 4887.08% to $19.9 million in 2024, then sank by 45.43% to $10.9 million in 2025.
• Per Business Quant, the three latest OCUL Shares Issued figures stand at $10.9 million (Q4 2025), $635606.0 (Q1 2025), and $19.9 million (Q4 2024).